close
close
orange

Shenzhen FRD Science & Technology First Quarter 2024 Profit: EPS: CN¥0.041 (vs. CN¥0.049 loss in first quarter 2023)

Vaseline

Shenzhen FRD Science & Technology (SZSE:300602) First Quarter 2024 Results

Main financial results

  • Revenue: CN¥982.4 million (up 27% from Q1 2023).
  • Net profit: CN¥23.6 million (versus the loss of CN¥25.1 million in the first quarter of 2023).
  • Profit margin: 2.4% (higher than the net loss in the first quarter of 2023).
  • EPS: CN¥0.041 (vs. loss of CN¥0.049 in Q1 2023).
profit and sales history
SZSE:300602 Profit and turnover history May 1, 2024

All figures in the chart above are for the subsequent 12 month period (TTM).

Shenzhen FRD profit insights in science and technology

Looking ahead, sales are expected to grow at an average annual rate of 36% over the next two years, compared to an 18% growth forecast for China’s electrical industry.

Performance of the Chinese electrical industry.

The company’s shares are up 7.2% from a week ago.

Risk analysis

Before you take the next step, you should be aware of the 3 warning signs for Shenzhen FRD Science & Technology (1 makes us a little uncomfortable!) that we discovered.

Valuation is complex, but we help make it simple.

Invent or Shenzhen FRD Science and Technology may be over or undervalued if you look at our comprehensive analysis, including fair value estimates, risks and cautions, dividends, insider transactions and financial health.

View the Free Analysis

Do you have feedback on this article? Worried about the content? Please contact us directly from us. You can also email the editorial team (at) Simplywallst.com.

This article from Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts using only an unbiased methodology and our articles are not intended as financial advice. It is not a recommendation to buy or sell any stock and does not take into account your objectives or financial situation. We aim to provide you with targeted, long-term analysis based on fundamental data. Please note that our analysis may not take into account the latest price-sensitive company announcements or quality material. Simply Wall St has no positions in the stocks mentioned.

Related Posts